NCT06481046

Treatment of Rotator Cuff Tears With Platelet Rich Plasma

• Status: Withdrawn
• Phase: N/A
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: The Foundation for Orthopaedics and Regenerative Medicine · Academic / Other
• Sex: All
• Age: 18 Years – 90 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to evaluate the safety and effectiveness of dual platelet rich plasma (PRP) injections into the rotator cuff insertion and the area of the tendon proximal to the insertion.

Detailed description

Patients who have rotator cuff pathology as established by clinical exam and confirmed with MRI and have failed activity modification, will be enrolled in this study. They will receive dual platelet rich plasma (PRP) injections, one into the rotator cuff insertion and one into the area of the tendon proximal to the insertion, in one treatment session. PRP will be prepared through a double spin technique to create two 4 cc doses for injection. Patients will evaluated at 6 months, 1 year and two years for improvement in symptoms.

Conditions

• Rotator Cuff Tears
• Rotator Cuff Tendinitis

Interventions

Type	Name	Description
BIOLOGICAL	Platelet Rich Plasma (PRP)	Platelet Rich Plasma (PRP) prepared from patient blood, spun twice to concentrate platelets. 45 cc of initial blood resulting in 4cc of injectable PRP.

Timeline

• Start date: 2015-01-23
• Primary completion: 2015-01-25
• Completion: 2015-01-25
• First posted: 2024-07-01
• Last updated: 2024-07-01

Locations

1 site across 1 country: United States